NCT07073794
Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer
At risk: Primary completion moved 33 days later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 8 versions: 7 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Start date: Aug 27, 2025 to Jan 22, 2026
- Eligibility criteria expanded, about 35 words
- Primary and study completion pushed from Aug 27, 2028 to Sep 29, 2028
- Secondary endpoints: details revised at 5 of 5 entries
- Notable Eligibility criteria expanded, about 1 wordv6
- Minor Collaborators expanded, about 5 wordsv5
- Notable Eligibility criteria expanded, about 64 wordsv4
- Notable Trial status: Not Yet Recruiting to Recruiting
- Primary and study completion dates: Jun 19, 2028 to Aug 27, 2028
- Start date changed from estimate of Sep 1, 2025 to Aug 27, 2025
- Site details revised
- Notable Eligibility criteria expanded, about 11 wordsv2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Patient rating of overall cancer care experience - CAHPS
Timeframe: Up to 48 weeks
Patient preferences regarding the location of cancer treatment delivery
Timeframe: Up to 48 weeks
Incidence of grade 3+ adverse events (AEs)
Timeframe: Up to 30 days after last dose of study treatment
Acute care visits, emergency room visits, and hospitalizations
Timeframe: Up to 48 weeks
Avoidable acute care visits, emergency room visits and hospitalizations
Timeframe: Up to 48 weeks
Secondary (5)
Patient-reported function and global health status/quality of life
Patient-reported symptoms as measured by Patient Reported Outcomes (PRO)-CTCAE
Patient-reported symptoms as measured by Functional Assessment of Cancer Therapy General Population 5 (FACT GP5)
Patient Satisfaction and Feedback Questionnaire
Patient satisfaction - Was It Worth It Questionnaire
Arms and interventions
Treatment (in clinic treatment, in home treatment)Experimental
Patients receive standard of care treatment in the clinic for 6-12 weeks then receive treatment in the home with CCBW for 12-24 weeks in the absence of disease progression or unacceptable toxicity. Patients receive any remaining treatment in the clinic.
Drugs: Cancer Therapeutic Procedure
Other: Health Care Delivery, Questionnaire Administration
Sites
1 site in 1 country
- Mayo Clinic in FloridaJacksonville, Florida, United States